Pharmaceuticals, Biotechnology and Life Sciences
WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., Presiden…
Approval is based on the Phase 3 ASPEN trial of BRUKINSA compared to ibrutinib
This marks the first regulatory approval for BRUKINSA in Waldenström’s macroglobulinemia, and BeiGene’s first approval in Canada
CAMBRIDGE, Mass. & BEIJING–(BUSINESS …
REDWOOD CITY, Calif.–(BUSINESS WIRE)–AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company developing innovative treatments with its proprietary dual anti-inflammatory/anti-fibrotic therapeutic platform targeting the colony-st…
– SER-287 Phase 2b study in patients with mild-to-moderate ulcerative colitis has achieved target enrollment; topline data expected in mid-2021 –
– Continued enrollment in SER-109 open label study in recurrent C. difficile infection to support planne…
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …
– Interim data readout expected in the third quarter of 2021 –
NESS ZIONA, Israel–(BUSINESS WIRE)–BiomX Inc. (NYSE American: PHGE), a clinical-stage company developing both natural and engineered phage therapies that target specific pathogenic bact…
– RLYB212: A Novel Monoclonal HPA-1a Antibody for the Prevention of a Potentially Life-Threatening Rare Disease that Impacts Fetuses and Newborns –
– RLYB116: A Novel Small Protein Inhibitor of Complement C5 for the Treatment of Patients with Severe …
BOSTON–(BUSINESS WIRE)–AVEO Oncology (Nasdaq: AVEO) today announced that Michael Bailey, president and chief executive officer of AVEO, will present at the H.C. Wainwright Global Life Sciences Conference, being held virtually on March 9-10, 2021.
A …
Company will provide business updates during the earnings call and release investor day video segments on Company website
CLEVELAND–(BUSINESS WIRE)–$ATHX #Athersys–Athersys, Inc. (Nasdaq: ATHX) will release its year-end 2020 financial results at ap…
– Vaccine Candidate Previously Demonstrated Antibodies and T-cell Response in Mouse Models –
– Clinical Trial to Serve as Initial Validation of LinearDNA Platform in Large Mammals with Potential Advantages in Manufacturing, Storage, and Distribution…